- 601. DIFFUSE CHOLESTEATOSIS
- (UMLS (ICD9CM) C0155491) =Disease or Syndrome ;
| - 651. digestion
- [process of breakdown of food for metabolism and use by the body. ( CSP )] (UMLS (CSP) C0012238) =Organism Function =gastrointestinal function;
|
- 602. Diffuse Cutaneous Mastocytosis
- [A variant of cutaneous mastocytosis which is seen almost exclusively in children. (WHO, 2001) — 2003 ( NCI )] (UMLS (NCI) C0024901) =Disease or Syndrome
| - 652. DIGESTIVE
- [group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste; in humans, the digestive system includes the gastrointestinal tract (mouth, esophagus, stomach, intestines, anus) and the accessory glands (liver, biliary tract, pancreas), and associated hormones and secretions.(CSP)] (UMLS (ICPC) C0012240) (DIGESTIVE; (194); (115); (116); (104); (105); (106); (108); (119); (133); (130); (122); (123)) Body System, Gastrointestinal =Body System =Body System, Gastrointestinal; anatomy; International Classification of Primary Care; =Bile Tract; Body System, Gastrointestinal; Body System, Hepatic; Gastrointestinal Tract, Pancreas; esophagogastric junction; esophagus; More…
|
- 603. Diffuse Dysplasia
- (UMLS (NCI) C0522619) =Cell or Molecular Dysfunction
| - 653. digestive cancer
- [A primary or metastatic malignant neoplasm involving any part of the gastrointestinal system. — 2003 ( NCI )] (UMLS (CSP) C0685938) =Neoplastic Process
|
- 604. Diffuse Follicle Centre Lymphoma
- (UMLS (NCI) C1333290) Follicle Centre Lymphoma Diffuse =Neoplastic Process ;
| - 654. Digestive Diseases
- [disorders of any of the organs that are associated with ingestion, digestion, and absorption of food. ( CSP )] (UMLS (NCI) C0012242) =Disease or Syndrome =Disease;
Diseases, Manifestations or Physiologic States =Biliary Tract Disease;
digestive neoplasm;
Gastrointestinal Diseases;
Hepatic Disorder;
Diseases of pancreas;
peritonitis;
dental disorder;
Biliary Tract Disease;
digestive neoplasm;
Diverticulum;
Disease of esophagus;
Gastrointestinal Diseases;
Hepatic Disorder;
Diseases of pancreas;
Peritoneal Disease;
Digestive System Fistula;
ANOM DIGESTIVE SYST NOS |
- 605. Diffuse Giant Cell Neoplasm of Tendon Sheath
- [A locally aggressive, diffusely infiltrating tumor, arising in the tendon sheath. It is composed of synovial-like mononuclear cells, hemosiderin-laden macrophages, foam cells, and inflammatory cells. Multinucleated osteoclast-like giant cells are usually present, although in a minority of cases they may be absent or rare. It predominantly affects young adults. Symptoms include joint swelling, pain, and joint effusion. ( NCI )] (UMLS (NCI) C0039106) =Disease or Syndrome =synovitis;
| - 655. digestive neoplasm
- [new abnormal digestive system tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease; includes neoplasms of any of the organs that are associated with ingestion, digestion, and absorption of food. ( CSP )] (UMLS (CSP) C0012243) =Neoplastic Process =Digestive Diseases;
Neoplasm by Site;
neoplasm/cancer site;
=Biliary Neoplasm;
Digestive Neoplasm;
hepatic neoplasm;
Neoplasm of Pancreas;
peritoneal neoplasm;
Biliary Neoplasm;
esophageal cancer;
Digestive Neoplasm;
hepatic neoplasm;
Neoplasm of Pancreas;
peritoneal neoplasm |
- 606. Diffuse Glomerulonephritis
- (UMLS (NCI) C0859036) =Disease or Syndrome
| - 656. Digestive Neoplasm
- [new abnormal gastrointestinal tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease; use for general gastrointestinal tract neoplasms. ( CSP )] (UMLS (NCI) C0017185) =Neoplastic Process ;
=digestive neoplasm;
Gastrointestinal Diseases =esophageal cancer;
intestinal neoplasm;
Neoplasm of Pharynx;
Gastric Neoplasm;
intestinal neoplasm;
Gastric Neoplasm |
- 607. Diffuse Hyperplasia of Bronchus-Associated Lymphoid Tissue
- [Mitelman_Code: 201 ( NCI )] (UMLS (NCI) C0264511) =Disease or Syndrome
| - 657. DIGESTIVE PROBLEMS NEC
- [ ] (UMLS (ICD9CM) C0260708) =Finding
|
- 608. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia
- (UMLS (NCI) C1333291) DIPNECH;
DIP-NECH;
=Disease or Syndrome ;
| - 658. Digestive Stromal Neoplasm
- [A KIT-expressing and KIT-signaling-driven mesenchymal tumor involving any part of the gastrointestinal tract. It originates from the interstitial cells of Cajal. Morphologic variants include the epithelioid cell type, spindle cell type, and mixed cell type. Lesions with a diameter greater than 10cm and more than 5 mitotic figures per 50HPF tend to have a more aggressive clinical course. Until recently, surgery has been the only effective therapy for GIST. However, many patients still experience recurrence. A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable GIST. ( NCI )] (UMLS (NCI) C1333802) Digestive Stromal Tumor;
Digestive Tract Stromal Neoplasm;
Digestive Tract Stromal Tumor;
Gastrointestinal Stromal Tumor of Gastrointestinal Tract;
Gastrointestinal Stromal Tumor of the Gastrointestinal Tract;
Gastrointestinal Tract Stromal Neoplasm;
Gastrointestinal Tract Stromal Tumor;
Stromal Neoplasm of Digestive Tract;
Stromal Neoplasm of Gastrointestinal Tract;
Stromal Neoplasm of the Digestive Tract;
Stromal Neoplasm of the Gastrointestinal Tract;
Stromal Tumor of Digestive Tract;
Stromal Tumor of Gastrointestinal Tract;
Stromal Tumor of the Digestive Tract;
Stromal Tumor of the Gastrointestinal Tract =Neoplastic Process |
- 609. Diffuse Infiltrative Lymphocytosis Syndrome
- [This is usually an oligoclonal CD8+ lymphocytic infiltration of various organs. ( NCI )] (UMLS (NCI) C1333292) =Disease or Syndrome ;
| - 659. Digestive Stromal Neoplasm of Small Intestine
- (UMLS (NCI) C1335996) Digestive Stromal Neoplasm of the Small Intestine;
Digestive Stromal Tumor of Small Intestine;
Digestive Stromal Tumor of the Small Intestine;
Gastrointestinal Stromal Neoplasm of Small Intestine;
Gastrointestinal Stromal Neoplasm of the Small Intestine;
Gastrointestinal Stromal Tumor of Small Intestine;
Gastrointestinal Stromal Tumor of the Small Intestine;
Small Intestinal Gastrointestinal Stromal Tumor;
Small Intestinal GIST;
Small Intestine Digestive Stromal Neoplasm;
Small Intestine Digestive Stromal Tumor;
Small Intestine Gastrointestinal Stromal Neoplasm;
=Neoplastic Process |
- 610. diffuse interstitial pulmonary fibrosis
- [chronic inflammation and progressive fibrosis of the pulmonary alveolar walls with steady progressive dyspnea; finally, resulting in death from lack of oxygen or right heart failure. ( CSP )] (UMLS (CSP) C0085786) =Disease or Syndrome ;
=pulmonary fibrosis/granuloma;
| - 660. Digestive Stromal Neoplasm of Stomach
- (UMLS (NCI) C1333768) Digestive Stromal Neoplasm of the Stomach;
Digestive Stromal Tumor of Stomach;
Digestive Stromal Tumor of the Stomach;
Gastric Digestive Stromal Neoplasm;
Gastric Digestive Stromal Tumor;
Gastric Gastrointestinal Stromal Tumor;
Gastric GIST;
Gastrointestinal Stromal Neoplasm of Stomach;
Gastrointestinal Stromal Neoplasm of the Stomach;
Gastrointestinal Stromal Tumor of Stomach;
Gastrointestinal Stromal Tumor of the Stomach;
GIST of Stomach;
GIST of the Stomach;
Stomach Digestive Stromal Neoplasm;
Stomach Digestive Stromal Tumor =Neoplastic Process |
- 611. Diffuse Intraductal Papillomatosis
- (UMLS (NCI) C1377912) =Neoplastic Process
| - 661. Digestive system complications
- [ ] (UMLS (ICD9CM) C1455907) SURG COMP-DIGESTV SYSTEM;
=Pathologic Function |
- 612. Diffuse Large B-Cell Lymphoma
- [A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes. It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases. Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, T-cell/histiocyte rich lymphoma, anaplastic lymphoma, plasmablastic lymphoma, and diffuse large B-cell lymphoma with expression of full-length ALK. (WHO, 2001) ( NCI )] (UMLS (NCI) C0079744) =Neoplastic Process =histiocytic lymphoma;
Lymphoma, Undifferentiated;
Lymphoma, Diffuse;
Intermediate Grade Lymphoma | - 662. digestive system operative procedure
- [Surgery performed on any part of the digestive system. ( NCI )] (UMLS (NCI) C0038898) =Therapeutic or Preventive Procedure ;
|
- 613. Diffuse Large B-Cell Lymphoma of the Thyroid
- [A diffuse large B-cell lymphoma primarily involving the thyroid gland. (NCI05) ( NCI )] (UMLS (NCI) C1336749) Diffuse Large B-Cell Lymphoma of the Thyroid Gland;
Diffuse Large B-Cell Lymphoma of Thyroid;
Diffuse Large B-Cell Lymphoma of Thyroid Gland;
Primary Thyroid Gland Diffuse Large B-Cell Lymphoma;
Thyroid Diffuse Large B-Cell Lymphoma;
Thyroid Gland Diffuse Large B-Cell Lymphoma =Neoplastic Process ;
| - 663. Digestive tract instillation, except gastric gavage
- (UMLS (ICD9CM) C0846510) GI TRACT INSTILLAT NEC;
=Therapeutic or Preventive Procedure |
- 614. Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder
- (UMLS (NCI) C1333293) Diffuse Large B-Cell Lymphoma PTLD =Neoplastic Process ;
| - 664. DIGESTIVE TRACT XRAY NEC
- [ ] (UMLS (ICD9CM) C0177743) =Diagnostic Procedure
|
- 615. Diffuse Large B-Cell Lymphoma Refractory
- [Diffuse large B-cell lymphoma that is resistant to treatment. ( NCI )] (UMLS (NCI) C0855112) Refractory Diffuse Large B-Cell Lymphoma;
=Neoplastic Process | - 665. DIGESTVE SYST SYMPTM NEC
- [ ] (UMLS (ICD9CM) C0159061) =Sign or Symptom
|
- 616. Diffuse Large B-Cell Lymphoma Stage I
- [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE).- 2003 ( NCI )] (UMLS (NCI) C0855113) Stage I Diffuse Large B-Cell Lymphoma;
=Neoplastic Process | - 666. Digit
- [A finger or toe in human beings or corresponding part in other vertebrates. ( NCI )] (UMLS (NCI) C0582802) =Body Part, Organ, or Organ Component =Body Part;
|
- 617. Diffuse Large B-Cell Lymphoma Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C0855114) Stage II Diffuse Large B-Cell Lymphoma;
=Neoplastic Process | - 667. DIGITAL ENTEROSTOMY EXAM
- [ ] (UMLS (ICD9CM) C0199885) =Diagnostic Procedure
|
- 618. Diffuse Large B-Cell Lymphoma Stage III
- [Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). - 2003 ( NCI )] (UMLS (NCI) C0855115) Stage III Diffuse Large B-Cell Lymphoma;
=Neoplastic Process | - 668. DIGITAL EXAM OF UTERUS
- [ ] (UMLS (ICD9CM) C0177195) =Diagnostic Procedure
|
- 619. Diffuse Large B-Cell Lymphoma Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0855116) Stage IV Diffuse Large B-Cell Lymphoma;
=Neoplastic Process | - 669. Digital examination of rectum
- [DRE. An examination in which a doctor inserts a lubricated, gloved finger into the rectum to feel for abnormalities. ( NCI )] (UMLS (ICD9CM) C1384593) DIGITAL RECTAL EXAM;
digital rectal examination;
DRE =Diagnostic Procedure ;
|
- 620. Diffuse Large B-Cell Lymphoma with a Germinal Center B-Cell Expression Profile
- [A biologic subset of diffuse large B-cell lymphomas with a unique molecular signature or expression profile. It represents approximately 50% of diffuse large B-cell lymphomas, and is characterized by the expression of CD10, BCL-6, A-myb, and LMO2 genes, BCL-2 translocation, and c-REL amplification. Morphologically, the vast majority of these lymphomas are centroblastic and a small minority are immunoblastic (ratio20:1). Patients with this type of diffuse large B-cell lymphoma have a more favorable outcome, with a 5-year survival rate of 60% and a median survival of 10 years. — 2004 ( NCI )] (UMLS (NCI) C1333295) GCB-DLBCL;
Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma;
=Neoplastic Process ;
| - 670. Digital Fibrous Tumor of Reye
- [A rare benign neoplasm arising from the soft tissues of the digits, in young children. It is characterized by the presence of fibroblastic spindle cells, and intracytoplasmic eosinophilic spherical inclusions. ( NCI )] (UMLS (NCI) C1318562) Inclusion Body Fibromatosis;
Infantile Digital Fibromatosis;
Reye's Tumor;
=Neoplastic Process ;
|
- 621. Diffuse Large Cell Type Lymphomatoid Papulosis
- [A variant of lymphomatoid papulosis characterized clinically by regressing skin papules, and morphologically by features resembling anaplastic large cell lymphoma. ( NCI )] (UMLS (NCI) C1333297) Diffuse Large Cell Type LyP;
Type C Lymphomatoid Papulosis;
Type C LyP =Neoplastic Process ;
| - 671. Digital Imaging and Communications in Medicine
- (UMLS (HL7) C1548451) =Intellectual Product ;
=Subtype of referenced data;
|
- 622. Diffuse Lipomatosis
- [A neoplastic process characterized by a diffuse poorly circumscribed overgrowth of adipose tissue. It has been associated with several genetic disorders and different clinical conditions such as liver disease, excessive alcohol intake, adrenocortical steroid therapy, and antiretroviral therapy. ( NCI )] (UMLS (NCI) C1333298) =Neoplastic Process ;
| - 672. Digital Mammography
- [Digital mammography assists in the early detection of breast cancer by incorporating modern electronics and computers into x-ray mammography methods. Instead of acquiring an image on film, it is collected electronically and can be stored directly into a computer. Digital mammography is quick and has the potential to reduce patient anxiety and inconvenience. Moreover, digital mammograms are easily archived and electronically transferable, making them ideal for teaching purposes and for evaluation during long-distance telemedicine consultations. ( NCI )] (UMLS (NCI) C0860950) =Diagnostic Procedure
|
- 623. Diffuse Malignant Lymphoma
- (UMLS (NCI) C0334620) =Neoplastic Process
| - 673. Digital microscopy
- (UMLS (HL7) C1547107) =Diagnostic Procedure =Modality;
|
- 624. Diffuse Malignant Mesothelioma
- (UMLS (NCI) C0392400) =Neoplastic Process ;
| - 674. Digital Papillary Carcinoma
- [An adenocarcinoma arising from the sweat glands. Most cases present as nodular lesions on the digits, usually in the hands. It is characterized by the presence of epithelial cells in the dermis forming nodules. Cystic structures containing papillary projections are also present. It may recur and metastasize, most commonly to the lungs. ( NCI )] (UMLS (NCI) C1367789) Digital Papillary Eccrine Carcinoma;
Papillary Digital Eccrine Carcinoma;
=Neoplastic Process ;
|
- 625. Diffuse Melanocytosis
- [Diffuse Melanocytosis is a diffuse or multifocal proliferation of uniform nevoid polygonal cells in the leptomeninges. Cells may spread into the Virchow-Robin spaces without frank invasion of the brain. Diffuse Melanocytosis carries a poor prognosis even in the absence of histologic malignancy. (WHO) ( NCI )] (UMLS (NCI) C1266112) Diffuse Melanosis;
Diffuse Meningeal Melanocytosis;
=Neoplastic Process | - 675. Digital Vein
- (UMLS (NCI) C0447128) =Body Part, Organ, or Organ Component
|
- 626. Diffuse Mixed Cell Lymphoma
- (UMLS (NCI) C0079757) =Neoplastic Process =Lymphoma, Mixed-Cell;
Lymphoma, Diffuse;
Intermediate Grade Lymphoma;
| - 676. digital video imaging
- [ ] (UMLS (CSP) C0872144) digital video recording =Human-caused Phenomenon or Process; Manufactured Object ;
|
- 627. Diffuse Neurofibroma
- (UMLS (NCI) C0432361) =Neoplastic Process
| - 677. Digital X-Ray
- [Acquisition or display of radiographic images using digital techniques; includes digital video fluoroscopy, scan-projection radiography (SPR), digital subtraction and angiography (DSA), digital intravenous angiography (DIVA), and computed tomography. (CRC Dictionary and Handbook of Nuclear Medicine and Clinical Imaging, 1990) ( NCI )] (UMLS (NCI) C0442015) =Intellectual Product
|
- 628. diffuse optical tomography
- [ ] (UMLS (CSP) C1328868) =Diagnostic Procedure; ;
| - 678. DIGITALIN
- [A glycoside compound, extracted from the leaves and seeds of the common foxglove, with anti-arrhythmic property. Digitalin inhibits the enzymatic activity of the sodium-potassium ATPase pump in cardiac tissue, thereby increasing intracellular sodium and calcium levels and providing a positive inotropic effect. This results in increased force of myocardial muscle contraction. This agent also has a vagal effect on the parasympathetic nervous system, and as such slows the ventricular heart rate as well as helps eliminate fluid from body tissues. ( NCI )] (UMLS (NCI) C0058012) =Steroid; Pharmacologic Substance ;
|
- 629. Diffuse Palmoplantar Keratoderma
- [An autosomal dominant disorder characterized by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma (KERATODERMA, PALMOPLANTAR), as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present. ( MSH )] (UMLS (NCI) C0022584) =Disease or Syndrome ;
=Keratoderma, Palmoplantar;
| - 679. digitalis
- [extract from genus of toxic herbaceous Eurasian plants of the Scrophulaceae which yield cardiotonic digitalis glycosides; most useful species are Digitalis lanata and D. purpurea. ( CSP )] (UMLS (CSP) C0304520) =Organic Chemical; Pharmacologic Substance =[CV050] DIGITALIS GLYCOSIDES;
plant extract;
Unclassified Ingredients;
=DIGITALIS,POWDERED |
- 630. Diffuse Pattern
- [A morphologic architectural pattern in which a cellular population is distributed in a relatively uniform fashion throughout a specified tissue area; not focal. ( NCI )] (UMLS (NCI) C1333299) =Finding ;
| - 680. Digitalis Toxicity
- (UMLS (NCI) C0012254) =Injury or Poisoning
|
- 631. Diffuse Peritoneal Leiomyomatosis
- [A condition characterized by the presence of numerous small benign smooth muscle neoplasms growing throughout the female pelvis. It is usually associated with pregnancy. ( NCI )] (UMLS (NCI) C0267785) =Neoplastic Process ;
| - 681. digitonin
- [steroid saponin (soapy glucoside) derived from digitalis, used as a cholesterol indicator (the complex precipitates). ( CSP )] (UMLS (CSP) C0012256) =Carbohydrate; Indicator, Reagent, or Diagnostic Aid ;
=Glycoside;
|
- 632. Diffuse Pulmonary Fibrosis
- (UMLS (NCI) C0865849) =Disease or Syndrome ;
| - 682. digitoxigenin
- [3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin. ( MSH )] (UMLS (CSP) C0012257) =Steroid; Pharmacologic Substance
|
- 633. Diffuse Retinoblastoma
- (UMLS (NCI) C1266185) =Neoplastic Process
| - 683. digoxigenin
- [3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh. ( MSH )] (UMLS (CSP) C0012264) =Steroid; Pharmacologic Substance; Biologically Active Substance ;
|
- 634. Diffuse secondary atrophy of choroid
- [ ] (UMLS (ICD9CM) C0154892) =Disease or Syndrome
| - 684. digoxin
- [cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone digoxigenin; digoxin has positive inotropic and negative chronotropic activity; used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation; its use in congestive heart failure and sinus rhythm is less certain; the margin between toxic and therapeutic doses is small. ( CSP )] (UMLS (CSP) C0012265) =Steroid; Carbohydrate; Pharmacologic Substance ;
=cardenolide;
cardiac glycoside;
[CV050] DIGITALIS GLYCOSIDES;
=DIGOXIN 0.05 MG;
DIGOXIN 0.05 MG/ML;
DIGOXIN 0.1 MG;
DIGOXIN 0.125 MG;
DIGOXIN 0.2 MG;
DIGOXIN 0.25 MG;
DIGOXIN 0.25 MG/ML;
DIGOXIN 0.1 MG/ML;
DIGOXIN 0.5 MG |
- 635. diffuse systemic sclerosis
- [A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability. ( MSH )] (UMLS (CSP) C1258104) =Disease or Syndrome ;
| - 685. DIHYDROERGOTAMINE
- [A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS. ( MSH )] (UMLS (NCI) C0012291) =Organic Chemical; Pharmacologic Substance =[CN105] ANTIMIGRAINE AGENTS;
Ergotamine Derivatives =9,10-Dihydroergotamine Mesylate |
- 636. Diffuse Type Adenocarcinoma
- [An adenocarcinoma characterized by the presence of a diffuse cellular infiltrate which is composed of poorly cohesive cells with minimal or no glandular formations. Representative example is the gastric diffuse adenocarcinoma. ( NCI )] (UMLS (NCI) C0334280) =Neoplastic Process
| - 686. dihydronicotinamide adenine dinucleotide
- [coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage; found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). ( CSP )] (UMLS (CSP) C0027270) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=adenine nucleotide;
cofactor;
high energy compound;
nicotinamide ribotide |
- 637. diffusion
- [tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space; a major mechanism of biological transport. ( CSP )] (UMLS (CSP) C0012222) =Natural Phenomenon or Process =Physical Phenomenon;
| - 687. dihydropyridine receptor
- [ ] (UMLS (CSP) C0218111) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 638. Diffusion
- [Diffusion ( HL7V3.0 )] (UMLS (HL7) C1696141) =Functional Concept =RouteByMethod;
=Diffusion, extracorporeal;
Diffusion, hemodialysis;
Diffusion, transdermal;
| - 688. Dihydropyrimidine Dehydrogenase
- [An enzyme involved in pyrimidine catabolism. Increased DPD levels can influence tumor response to 5-fluorouracil-based chemotherapy through increased inactivation of the agent in tumor cells. Increases of the DPD mRNA level in cancerous tissue seem to reflect tumor progression. High DPD mRNA levels in liver metastasis and advanced colorectal cancer may have clinical importance for 5-fluorouracil-based chemosensitivity. (from Ann Surg Oncol 2002;9:599-603) ( NCI )] (UMLS (NCI) C0058126) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 639. diffusion magnetic resonance imaging
- [MRI method that measure the diffusion of water in the tissue, rather than the content of water as measured in conventional MRI. ( NCI )] (UMLS (CSP) C1136216) Diffusion MRI;
=Diagnostic Procedure =magnetic resonance imaging;
| - 689. Dihydropyrimidine Dehydrogenase Gene
- [This gene is involved in pyrimidine catabolism. ( NCI )] (UMLS (NCI) C1366555) DPYD;
DPYD Gene =Gene or Genome |
- 640. diffusion weighted imaging
- [ ] (UMLS (CSP) C0598801) =Diagnostic Procedure ;
| - 690. DIHYDROSTREPTOMYCIN
- [A derivative of streptomycin, aminoglycoside antibiotic, with bactericidal property. Dihydrostreptomycin depends on active transport across the bacterial cell membrane before irreversibly binding S12 protein of the bacterial 30S ribosomal subunit. As a result, this agent interferes with the initiation complex between messenger RNA and the bacterial ribosome thereby causing the misreading of the genetic code resulting in the production of non-functional proteins, consequently leading to bacterial cell death. ( NCI )] (UMLS (NCI) C0262967) =Carbohydrate; Antibiotic
|
- 641. Diffusion, extracorporeal
- [Diffusion, extracorporeal ( HL7V3.0 )] (UMLS (HL7) C1552101) =Functional Concept =Diffusion;
ExtracorporealCirculationRoute | - 691. Dihydrostreptomycin Sequisulphate
- [A semi-synthetic aminoglycoside antibiotic with bactericidal properties. Dihydrostreptomycin sulfate inhibits protein synthesis by binding to the 30S ribosomal subunit. This antibiotic is active against most gram-positive and gram-negative organisms and is used in the treatment of tuberculosis and tulemia. ( NCI )] (UMLS (NCI) C0012317) =Carbohydrate; Antibiotic
|
- 642. Diffusion, hemodialysis
- [Diffusion, hemodialysis ( HL7V3.0 )] (UMLS (HL7) C1553207) =Functional Concept =Diffusion;
IntravascularRoute | - 692. Dihydrouracil Dehydrogenase Deficiency
- (UMLS (NCI) C0268132) =Disease or Syndrome ;
|
- 643. Diffusion, transdermal
- [Diffusion, transdermal ( HL7V3.0 )] (UMLS (HL7) C1554960) =Functional Concept =Cutaneous Route of Administration;
Diffusion | - 693. dihydroxyacetone
- [ketotriose compound; its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage; it is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes; in combination with naphthoquinones it acts as a sunscreening agent. ( CSP )] (UMLS (CSP) C0012322) =Carbohydrate; Pharmacologic Substance; Biomedical or Dental Material =Ketoses;
triose;
[DE900] DERMATOLOGICALS, TOPICAL OTHER;
=DIHYDROXYACETONE 5 % |
- 644. Difloxacin
- (UMLS (NCI) C0057993) =Organic Chemical; Antibiotic ;
| - 694. dihydroxyphenylalanine
- [D1 and D2 agonist; precursor in dopamine biosynthesis; levodopa or L-DOPA is the generic name of the antiparkinson drug. ( CSP )] (UMLS (CSP) C0013023) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine =[CN500] ANTIPARKINSON AGENTS;
catecholamine;
phenylalanine;
Dopamine Agonist =(--)-2Amino-3-)3,4-dihydroxyphenyl)propanoic Acid;
3-Hydroxy-alpha-methyl-L-tyrosine;
|
- 645. diflucan
- [ ] (UMLS (CSP) C0699601) =Organic Chemical; Pharmacologic Substance ;
| - 695. diketone
- [ ] (UMLS (CSP) C0598750) =Organic Chemical ;
|
- 646. DIFLUCORTOLONE PIVALATE
- (UMLS (NCI) C0770953) =Organic Chemical; Pharmacologic Substance ;
| - 696. Dilantin
- (UMLS (NCI) C0699512) =Organic Chemical; Pharmacologic Substance
|
- 647. DIFLUMIDONE
- (UMLS (NCI) C0057995) =Organic Chemical; Pharmacologic Substance ;
| - 697. DILAT ENTEROSTOMY STOMA
- (UMLS (ICD9CM) C0192810) =Therapeutic or Preventive Procedure
|
- 648. Digastric Muscle
- (UMLS (NCI) C0224155) =Body Part, Organ, or Organ Component
| - 698. DILAT FRONTONASAL DUCT
- [ ] (UMLS (ICD9CM) C0189094) =Therapeutic or Preventive Procedure
|
- 649. DiGeorge Anomaly
- [congenital syndrome with the absence of the thymus and parathyroids causing impairment of cellular immunity; immunoglobulin levels are normal. ( CSP )] (UMLS (NCI) C0012236) =Disease or Syndrome =hypoparathyroidism;
hypoimmunity;
syndrome;
DISEASE OF THYMUS NOS;
congenital disorder;
inborn immunodeficiency | - 699. dilate
- [(DYE-late) To widen or enlarge an opening or hollow structure beyond its usual size, such as the pupil of the eye or a blood vessel. ( NCI )] (UMLS (NCI) C0700124) =Functional Concept ;
|
- 650. DIGEST-GENIT FISTUL, FEM
- (UMLS (ICD9CM) C0012246) =Anatomical Abnormality
| - 700. DILATE PYLORUS, INCISION
- [ ] (UMLS (ICD9CM) C0176764) =Therapeutic or Preventive Procedure
|
home
